Ascendis Pharma A/S (ASND)

NASDAQ: ASND · Real-Time Price · USD

166.64

-3.80 (-2.23%)

At close: May 01, 2025, 3:59 PM

158.00

-5.18%

After-hours: May 01, 2025, 04:02 PM EDT

Ascendis Pharma A/S Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	363.64M	266.72M	51.17M	7.78M	6.95M	13.38M	10.58M	1.53M	4.61M
Cost of Revenue	44.26M	44.4M	12.14M	3.52M	n/a	n/a	n/a	n/a	n/a
Gross Profit	319.38M	222.32M	39.04M	4.25M	6.95M	13.38M	10.58M	1.53M	4.61M
Operating Income	-278.76M	-455.54M	-561.81M	-451.79M	-330.62M	-226.72M	-154.76M	-111.54M	-72.92M
Interest Income	14.36M	16.86M	52.18M	692K	1.81M	17.8M	4.02M	923K	123K
Pretax Income	-373.24M	-474.14M	-577.82M	-383.94M	-419.17M	-218.25M	-130.49M	-124.37M	-68.73M
Net Income	-378.08M	-481.45M	-583.19M	-383.58M	-418.95M	-218.02M	-130.1M	-123.9M	-68.5M
Selling & General & Admin	284.55M	264.41M	221.23M	160.18M	76.67M	48.47M	25.06M	13.48M	11.5M
Research & Development	307M	413.45M	379.62M	295.87M	260.9M	191.62M	140.28M	99.59M	66.02M
Other Expenses	6.6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	598.15M	677.86M	600.85M	456.05M	337.57M	240.09M	165.34M	113.07M	77.53M
Interest Expense	65.5M	44.06M	50.49M	3.91M	1.92M	1.22M	127K	97K	5K
Selling & Marketing Expenses	n/a	5.62M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	642.4M	722.26M	612.99M	459.57M	337.57M	240.09M	165.34M	113.07M	77.53M
Income Tax Expense	4.84M	7.3M	5.38M	-367K	-219K	-234K	-394K	-477K	-227K
Shares Outstanding (Basic)	57.89M	56.29M	56.07M	54.77M	50.62M	46.51M	41.09M	33.63M	26.56M
Shares Outstanding (Diluted)	57.89M	56.29M	56.07M	54.77M	50.62M	46.51M	41.09M	33.63M	26.56M
EPS (Basic)	-6.53	-8.55	-10.4	-7	-8.28	-4.69	-3.17	-3.68	-2.58
EPS (Diluted)	-6.53	-8.55	-10.4	-7	-8.28	-4.69	-3.17	-3.68	-2.58
EBITDA	-290.02M	-411.17M	-556.04M	-423.67M	-328.88M	-217.03M	-150.18M	-109.88M	-72.12M
EBIT	-307.74M	-430.08M	-547.13M	-380.03M	-417.26M	-217.03M	-130.36M	-124.28M	-68.73M
Depreciation & Amortization	17.71M	18.91M	17.63M	16M	8.8M	6.67M	908.17K	689.46K	710.02K